ArticleNeuro-oncology2019

A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma.

Howard ColmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.